Description

CJC-1295 NO DAC & Ipamorelin Blend (10mg)

This synergistic blend of CJC-1295 without DAC and Ipamorelin is designed for research into growth hormone release and anti-aging applications. CJC-1295 NO DAC is a shorter-acting GHRH analog that mimics the natural pulsatile release of growth hormone, while Ipamorelin is a selective ghrelin receptor agonist (GHRP) that triggers GH secretion with minimal side effects. Together, they may provide a powerful tool for research into lean muscle growth, fat loss, sleep quality, and recovery.

Properties

• Components:

  • CJC-1295 (NO DAC) – 5mg

  • Ipamorelin – 5mg

• CAS Numbers:

  • CJC-1295 (NO DAC): 863288-34-0

  • Ipamorelin: 170851-70-4

• Form: Lyophilized (freeze-dried) peptide powder

• Strength: 10mg per vial (5mg + 5mg)

• Appearance: White to off-white powder

• Storage: Store at -20°C; refrigerate reconstituted solution at 2–8°C

• Shelf Life: 36 months (lyophilized); 60 days once reconstituted (if refrigerated)

Benefit

• Stimulates natural growth hormone release via dual pathways

• Promotes lean muscle mass development

• Supports fat metabolism and reduction in adipose tissue

• May enhance sleep quality and cellular recovery

• Minimal impact on cortisol or prolactin levels (especially from Ipamorelin)

Dosage

For research use only. Standard research protocols involve subcutaneous administration of 100–300mcg of each compound (CJC-1295 NO DAC and Ipamorelin), 1–2 times daily, typically before sleep and/or post-exercise. Reconstitute with bacteriostatic water.